Systematic review and meta-analysis of robotic versus laparoscopic surgery for rectal cancer
Robotic surgery shows lower urinary retention for rectal cancer patients in a review of 6,121 cases.
This systematic review and meta-analysis evaluated robotic versus laparoscopic surgery in 6121 rectal cancer patients with 12.0 months of fo…
A review of 6,121 rectal cancer patients found robotic surgery led to less urinary retention than laparoscopic surgery, though other functio…
Electroacupuncture Shortens Time to First Defecation in Colorectal Cancer Surgery Patients
Electroacupuncture Speeds Gut Recovery After Colon Surgery
This randomized controlled trial enrolled 72 patients with malignant tumors of the sigmoid colon or rectum scheduled for laparoscopic surger…
You wake up after colon surgery. The cancer is out.
Preoperative model predicts lateral lymph node metastasis in rectal cancer
Doctors Can Now Predict Hidden Cancer Spread in Rectal Cancer Patients
This retrospective cohort study of 64 patients with rectal cancer evaluated a preoperative clinicoradiological model to predict lateral lymp…
This new tool could help doctors decide who really needs aggressive surgery — and who doesn’t.
Methylene blue arterial perfusion increases lymph node detection in rectal cancer resection patients
Blue Dye Helps Surgeons Find More Cancer Cells
A retrospective cohort study of 120 patients undergoing radical rectal cancer resection found that methylene blue arterial perfusion with he…
A simple blue dye injection helps surgeons find more cancer cells, leading to better treatment plans for people with rectal cancer.
Postoperative pain score and NACRT predict anastomotic leakage in rectal cancer patients after anterior resection
One Pain Score Could Save Your Stoma
A retrospective cohort study of 901 rectal cancer patients who underwent anterior resection found an overall anastomotic leakage incidence o…
A simple pain rating after surgery is the best early warning sign for a dangerous leak in the bowel connection.
Cognitive-behavioral sleep intervention with nutritional support improves sleep, survival in rectal cancer surgery patients
A Simple Pre-Surgery Habit Change Boosts Cancer Survival Rates
A single-center RCT of 186 stage I-III rectal cancer patients found that adding cognitive-behavioral sleep intervention with nutritional sup…
Teaching patients how to sleep and eat better before a major cancer surgery doesn’t just help them recover—it may help them live longer.
Dynamic ctDNA monitoring during neoadjuvant chemotherapy identifies high-risk rectal cancer patients
Blood test during chemo may help predict rectal cancer treatment response
A biomarker substudy of a multicenter RCT in 153 patients with low-/intermediate-risk locally advanced rectal cancer found that dynamic ctDN…
A blood test tracking tumor DNA during chemo can predict which rectal cancer patients won't respond well to treatment before surgery.
Ex vivo diffusion MRI characterizes tissue components in post-neoadjuvant rectal cancer specimens
Can a new MRI scan spot hidden rectal cancer after treatment?
An ex vivo imaging study of 5 fixed post-neoadjuvant therapy rectal cancer specimens found that diffusion MRI metrics (fractional anisotropy…
A new high-resolution MRI scan can spot hidden rectal cancer by measuring subtle water movement differences in treated tissue samples.
Qualitative analysis explores LARS self-management experiences via online peer support app
Rectal cancer survivors share experiences using online peer support app for bowel symptoms
A qualitative analysis of 45 rectal cancer survivors with low anterior resection syndrome (LARS) participating in an online peer support app…
Rectal cancer survivors found comfort in an online app where peer support and diet tips helped them manage painful bowel symptoms after surg…
Phase 2 Trial: SHR-1701 Plus Chemoradiotherapy for Advanced Rectal Cancer
Could a new drug boost treatment for severe colorectal cancer?
A Phase 2 trial is recruiting to evaluate SHR-1701 with chemoradiotherapy in severe CRC. Primary outcome is pCR.
A new drug combined with standard chemo and radiation aims to clear severe colorectal cancer before surgery in an upcoming trial.